Dr. Ashutosh Lal, MD

Dr. Lal practices at UCSF Benioff Children's Hospital Oakland in Oakland, California, part of University of California Health.

Dr. Lal's NPI, 1023048469, was assigned on July 3, 2006. Dr. Lal holds California license A80388.

Dr. Lal's primary practice is UCSF Benioff Children's Hospital Oakland, at 747 52nd Street, Oakland, CA 94609 in Alameda County. The practice phone is (510) 428-3000.

Dr. Lal's primary practice is UCSF Benioff Children's Hospital Oakland in Oakland, California, part of University of California Health. Dr. Lal is also affiliated with UCSF Helen Diller Medical Center at Parnassus Heights. The medical group on file is UCSF Medical Group. Dmand AI also links Dr. Lal to 2 more medical groups, 1 group practice or clinic and 1 school health center, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Lal practices, 4 sites in all. Vendor and product names are available with a free account.

Pediatric hematology-oncology is Dr. Lal's primary specialty in the NPI Registry, under taxonomy code 2080P0207X. Dr. Lal is board certified in pediatric hematology-oncology by the American Board of Pediatrics. Dr. Lal is licensed in California.

Dmand AI lists colorectal cancer among the conditions Dr. Lal treats.

CMS data shows 130 Medicare services from Dr. Lal across 2 procedure codes in 2024, for 25 Medicare patients. Medicare paid $13,633 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 25 Medicare patients who saw Dr. Lal in 2024. 44% of them have osteoporosis. Their average risk score is 1.74, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Lal's median patient age at 17, with 48% women.

In 2024, Dr. Lal wrote 17 Medicare Part D claims. They cover 1 drug, with $1,361,869 in total drug cost. In 2022, CMS named 65 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 87 out of 100 for Dr. Lal for performance year 2024, reported as part of a group. Dr. Lal accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Lal as offering telehealth.

Dmand AI links 52 papers to Dr. Lal, published from 2005 to 2025. 2021 was the busiest year, with 6. The most frequent topics are Thalassemia, beta-Thalassemia and Anemia, Sickle Cell. Dr. Lal has published most often in Indian J Pediatr. Dr. Lal's most frequent co-authors are Elliott P. Vichinsky, MD, Sylvia Singer, MD and Alexis Anne Thompson, MD.

Dmand AI links Dr. Lal to 3 clinical trials. Conditions studied include Iron Overload and Iron Metabolism Disorders. UCSF Benioff Children's Hospital Oakland sponsors the most, 2.

CMS Open Payments shows 39 general payments to Dr. Lal from 7 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 63% of the total. Celgene Corporation paid the most, $10,141. It also lists 2 research payments totaling $3,864 from 2016 to 2017.

Dr. Lal is in network with 10 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 8. Check the plan with the practice before a visit.